Pooled screening identifies combinatorial CAR signaling domains for next-generation CAR-M immunotherapies
Wang, Y.; Zuo, S.; Bao, H.; Zhang, Z.; Chen, Y.; Zhang, W.; Liu, Q.; Lu, Y.; Huang, Y.; Zheng, W.; Yang, N.; Ye, L.; Shen, P.
Show abstract
Chimeric antigen receptor-engineered macrophages (CAR-Ms) hold great promise for solid tumor immunotherapy. The intracellular domains (ICDs) of CARs determine the phenotypic output of therapeutic macrophages but remain largely unexplored. Here, we constructed a CAR library containing 131 unique signaling domains derived from native immune receptors and identified 17 ICDs that enhance macrophage phagocytosis, inflammatory responses, or tumor infiltration in vitro and in vivo. We further developed a scalable 3 barcode technology, CARode, to uniquely label and trace ICD variants within large-scale combinatorial CAR library and applied it to single-cell RNA sequencing and single-cell CAR analysis to assess the synergetic effects of ICD combinations on macrophage activation. Our approach uncovered a novel CD40-LY9-FCRL1 chimeric receptor that modulates the tumor microenvironment and improves solid tumor clearance. In conclusion, our findings demonstrate that pooled screening can accelerate the discovery of complex ICD constructs, providing a powerful platform for engineering macrophage-based immunotherapies.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.